独立董事工作细则 汉王科技股份有限公司 第一章 总则 第一条 为了进一步完善汉王科技股份有限公司（以下简称"公司"）的治理结 构，促进公司的规范运作，维护公司整体利益，保障全体股东特别是中小股东 的合法权益不受损害，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《上市公司独立董事管理办法》等法律、行政法规、规章及其他规 范性文件，以及《汉王科技股份有限公司章程》（以下简称"公司章程"）的 规定，制定本细则。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其主要股 东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独立 客观判断的关系的董事。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务。独立董事应当按照法 律、行政法规、中国证券监督管理委员会（以下简称"中国证监会"）规定、 证券交易所业务规则和公司章程的规定，认真履行职责，在董事会中发挥参与 决策、监督制衡、专业咨询作用，维护公司整体利益，保护中小股东的合法权 益。 第四条 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单 位或个人的影响。 第五条 公司聘任的独立董事原则上最多在三家境内上市公司（ ...

Revenue and Profitability - The company's revenue for Q3 2025 was ¥446,318,366.94, representing a 3.31% increase year-over-year, while year-to-date revenue reached ¥1,259,535,254.84, up 9.85% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2025 was -¥34,451,338.33, a decrease of 42.30% year-over-year, with a year-to-date net profit of -¥91,177,977.83, down 21.55%[5]. - Basic and diluted earnings per share for Q3 2025 were both -¥0.1409, reflecting a 42.32% decline compared to the same quarter last year[5]. - Net profit for the current period was a loss of ¥84,132,290.09, slightly improved from a loss of ¥84,977,619.14 in the previous period[40]. - The company reported a basic and diluted earnings per share of -0.3730, compared to -0.3069 in the previous period[40]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥1,924,654,331.70, a decrease of 1.40% from the end of the previous year[5]. - Total current assets amount to ¥1,408,194,973.29, a decrease from ¥1,444,677,064.80 at the beginning of the period[34]. - Total liabilities increased to ¥729,614,018.64 from ¥675,849,385.05, reflecting a rise in financial obligations[38]. - The total equity attributable to shareholders decreased to ¥1,052,230,019.45 from ¥1,140,861,994.51, indicating a decline in shareholder value[38]. Cash Flow - Cash flow from operating activities showed a net outflow of -¥214,939,318.84 year-to-date, marking a significant decline of 113.47%[5]. - Cash inflow from operating activities totaled $1.34 billion, an increase from $1.19 billion, representing a growth of 12.9%[43]. - Net cash flow from operating activities was -$214.94 million, compared to -$100.69 million in the previous period, indicating a decline of 113%[43]. - Total cash inflow from investing activities was $133.56 million, down from $158.40 million, representing a decrease of 15.7%[43]. - Cash outflow from investing activities totaled $153.69 million, compared to $203.88 million, showing a reduction of 24.6%[43]. - Net cash flow from financing activities was $174.27 million, significantly up from $35.18 million, reflecting an increase of 394%[43]. Expenses - Research and development expenses increased by ¥70,579,200, representing a 55.98% growth year-to-date, indicating a focus on innovation[15]. - Financial expenses rose by ¥11,544,400, a 140.97% increase year-over-year, primarily due to increased foreign exchange losses and reduced interest income[23]. - Total operating costs increased to ¥1,360,211,801.92, up 9.32% from ¥1,244,114,718.12 in the previous period[39]. - Cash paid for employee compensation was $395.69 million, compared to $328.77 million, reflecting an increase of 20.3%[43]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 60,128[31]. - Liu Yingjian holds 19.65% of shares, totaling 48,030,838 shares[31]. - The company has no preferred shareholders or significant changes in shareholder structure[33]. Other Financial Metrics - The company reported a tax expense of ¥27,458.86, down from ¥910,738.79 in the previous period, reflecting lower taxable income[40]. - Other comprehensive income after tax for the current period was ¥339,642.55, compared to ¥255,382.83 in the previous period, showing improvement in this area[40]. - The company’s third-quarter financial report was not audited[44].

Core Insights - Hanwang and JD Health have signed a cooperation agreement to launch the "Precise Measurement · Nurse at Home" initiative, providing home guidance and standardized measurement processes for users of Hanwang's K-type electronic blood pressure monitors in 20 cities across China [1] Group 1: Service Offering - The "Nurse at Home" service includes professional blood pressure measurement demonstrations, education on the K-type method, comparisons with traditional mercury sphygmomanometers, and personalized reminders for users [1] - The service aims to help users achieve accurate blood pressure measurements at home, closely resembling the experience in hospitals [1] Group 2: Target Market - The initial rollout of the service will cover key cities such as Shanghai, Tianjin, Chongqing, Wuhan, and Chengdu, and is available for users who have purchased the Hanwang K-type electronic blood pressure monitor [1] Group 3: Product Features - The newly launched Hanwang KSY3610 electronic blood pressure monitor not only measures blood pressure but also provides five key indicators: blood pressure, heart rate, pulse pressure, atrial fibrillation screening results, and irregular pulse alerts [1] Group 4: Industry Context - Hanwang has previously promoted the "Mercury-Free Action" to replace mercury sphygmomanometers in medical institutions, and the new "Nurse at Home" service complements this initiative by extending support to individual households [1]

Core Insights - The article discusses the seasonal increase in blood pressure among hypertension patients during autumn and winter, emphasizing the importance of accurate blood pressure measurement [1][3] - A collaboration between Hanwang and JD Health has been established to launch the "Precise Measurement: Nurse at Home" initiative, aimed at providing home guidance for blood pressure measurement in 20 cities across China [1][3] Group 1 - The "Precise Measurement: Nurse at Home" service includes four main components: demonstration of professional blood pressure measurement standards, explanation of the Korotkoff sound principle, comparison with traditional mercury sphygmomanometers, and personalized reminders for users [3] - The new Hanwang Korotkoff electronic blood pressure monitor KSY3610 provides five key indicators: blood pressure, heart rate, pulse pressure, atrial fibrillation screening, and irregular pulse detection, with alerts for potential health issues [3] - Measurement data from the KSY3610 can be transmitted in real-time to the Hanwang Health APP, allowing users and healthcare providers to track trends and generate reports for better health management [3] Group 2 - The service is initially available in major cities such as Shanghai, Tianjin, Chongqing, Wuhan, and Chengdu, targeting existing users of the Hanwang Korotkoff electronic blood pressure monitor [3]

Market Overview - The software development sector increased by 1.31% on the previous trading day, with Pinming Technology leading the gains [1] - The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1] Top Performers - Pinming Technology (6018889) closed at 144.00, up 9.51% with a trading volume of 45,800 lots and a transaction value of 632 million [1] - Longsoft Technology (688078) closed at 31.16, up 5.63% with a trading volume of 24,800 lots [1] - Shanda Diwei (688579) closed at 11.48, up 3.61% with a trading volume of 93,300 lots [1] Underperformers - Qilin Xinan (688152) closed at 49.53, down 3.26% with a trading volume of 30,700 lots [2] - ST Dongtong (300379) closed at 2.28, down 2.15% with a trading volume of 595,700 lots [2] - Shengbang Security (688651) closed at 38.82, down 1.99% with a trading volume of 22,300 lots [2] Capital Flow - The software development sector experienced a net outflow of 135 million from institutional investors and 523 million from speculative funds, while retail investors saw a net inflow of 658 million [2] - Notable net inflows from retail investors were observed in stocks like Zhinanzhen (300803) with 202 million [3] Individual Stock Capital Flow - Zhinanzhen (300803) had a net inflow of 202 million from institutional investors, while it faced a net outflow of 75.58 million from speculative funds [3] - Tonghuashun (300033) saw a net inflow of 125 million from institutional investors, with a net outflow of 23.33 million from speculative funds [3] - Dahan Technology (600288) had a net inflow of 38.63 million from institutional investors, but a net outflow of 46.73 million from retail investors [3]

Core Insights - Hanwang Technology experienced a stock decline of 1.53% on October 16, with a trading volume of 90.08 million yuan [1] - The company reported a financing buy-in of 5.77 million yuan and a financing repayment of 11.44 million yuan on the same day, resulting in a net financing outflow of 5.66 million yuan [1] - As of October 16, the total financing and securities lending balance for Hanwang Technology was 243 million yuan, representing 4.30% of its market capitalization [1] Financing Overview - On October 16, Hanwang Technology had a financing buy-in of 5.77 million yuan, with a current financing balance of 243 million yuan, which is above the 70th percentile of the past year [1] - The company had no securities lending activity on October 16, with a securities lending balance of 0 yuan, indicating a high level of inactivity in this area [1] Business Performance - As of June 30, Hanwang Technology had 56,100 shareholders, a decrease of 10.72% from the previous period, while the average number of circulating shares per shareholder increased by 12.01% to 3,700 shares [2] - For the first half of 2025, Hanwang Technology reported a revenue of 813 million yuan, reflecting a year-on-year growth of 13.81%, but the net profit attributable to shareholders was a loss of 56.73 million yuan, a decrease of 11.66% year-on-year [2] Shareholder Composition - As of June 30, 2025, the largest circulating shareholder was Hong Kong Central Clearing Limited, holding 21.75 million shares, an increase of 1.77 million shares from the previous period [2] - Dachen Zhongzheng 360 Internet+ Index A (002236) was noted as a new shareholder, holding 664,900 shares, ranking as the tenth largest circulating shareholder [2]

证券代码：002362 证券简称：汉王科技 公告编号：2025-033 汉王科技股份有限公司 关于董事、高级管理人员减持股份实施完毕公告 注：1）上表中持股比例为四舍五入 2）上表中"有限售条件股份"为高管锁定股 二、其他相关说明 1、本次减持与2025年8月1日预披露减持计划一致，本次减持符合 相关法律法规、深交所业务规则的规定。 公司董事、副总裁李志峰先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。本公司及董事会全体成员保证公告内容与 信息披露义务人提供的信息一致。 汉王科技股份有限公司（以下简称"公司"）2025 年 8 月 1 日于指 定信息披露媒体《证券时报》、《中国证券报》及巨潮资讯网 （www.cninfo.com.cn）披露了《关于董事、高级管理人员减持股份的预 披露公告》，持本公司股份 513,281 股（占本公司总股本的比例为 0.21%） 的公司董事、高级管理人员李志峰先生拟在减持计划公告之日起 15 个 交易日后的 3 个月内，以集中竞价方式减持本公司股份不超过 128,320 股（占本公司总股本的比例不超过 0.0525%）。 近日，公司收到董事 ...

Core Points - Hanwang Technology announced that its Vice President Li Zhifeng reduced his shareholding by selling 128,300 shares at a price of 24.92 yuan per share on October 9, 2025 [1] - The reduction accounted for 0.0525% of the company's total share capital, completing the planned reduction [1] - Following the sale, Li Zhifeng's total shareholding decreased from 513,300 shares to 385,000 shares, with his ownership percentage dropping from 0.2100% to 0.1575% [1] - The remaining 385,000 shares are subject to trading restrictions [1]

Core Viewpoint - Hanwang Technology (002362) announced that neither the company nor its controlling subsidiaries have provided guarantees to entities outside the scope of the consolidated financial statements, and there are no overdue guarantees or guarantees involved in litigation [1] Group 1 - The company confirmed the absence of guarantees to external entities [1] - There are no overdue guarantees reported by the company [1] - The company is not involved in any litigation related to guarantees [1]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、概述 汉王科技股份有限公司（以下简称"公司"）于2025年3月27日召开的 第七届董事会第五次会议及2025年5月21日召开的2024年度股东会审议通 过《关于对子公司提供担保额度预计的议案》，为支持公司各控股子公司 的业务发展，满足其日常生产经营的资金需要，在现存担保余额基础上， 公司拟为合并报表范围内的子公司向银行等金融机构申请综合授信事项新 增不超过3亿元的保证担保（含公司为子公司或子公司之间提供的担保）。 其中，对资产负债率70%以下的子公司新增担保额度合计不超过2亿元，对 资产负债率70%以上的子公司新增担保额度合计不超过1亿元，具体担保额 以实际发生额为准。详见公司2025年3月29日、2025年5月22日于指定信息 披露媒体证券时报、中国证券报、巨潮资讯网（www.cninfo.com.cn）披露 的相关公告。 证券代码：002362 证券简称：汉王科技 公告编号：2025-032 汉王科技股份有限公司 关于公司为控股子公司提供担保的进展公告 近日，公司全资子公司仿翼（北京）科技有限公司（以下简 ...